VINSE General News
-
Yueming Yan recipient of the 2024 VINSE Best Collaborative Paper Award
VINSE is excited to announce that Yueming Yan is the recipient of the 2024 VINSE Best Collaborative Paper award. Yueming’s paper has contributions from two VINSE groups from different departments – the Haglund group in Physics and the Macdonald group in Chemistry. Yueming designed a multi-layer nano composite film… Read MoreOct. 10, 2024
-
VINSE Expands Industry Affiliates Program to Include Government and Non-Profit Organizations
VINSE has broadened its newly established Industry Affiliates Program to welcome government and non-profit entities. The Royal Society of Chemistry (RSC) is the first organization to join under this expanded category. RSC, a prominent UK-based professional association, aims to advance excellence in the chemical sciences and its applications. With a… Read MoreOct. 10, 2024
-
VINSE Celebrates National Nanotechnology Day
On October 9, the Vanderbilt Institute of Nanoscale Science and Engineering (VINSE) celebrated National Nanotechnology Day, showcasing the remarkable innovations at the nanometer scale (10^-9 meters). The event included guided window tours of VINSE’s cutting-edge cleanroom, showcasing the pioneering research conducted at the institute. Attendees were treated to Ben… Read MoreOct. 10, 2024
-
Zhiliang Pan recipient of the 2024 VINSE Best Graduate Student Publication Award
Congratulations to Zhiliang Pan, recipient of the 2024 VINSE Best Graduate Student Publication award. Zhiliang’s publication in Nature reports on the first demonstration of direct experimental evidence for substantial heat conduction along SiC nanowires mediated by surface phonon polaritons (SPhPs), hybrid quasi-particles resulting from coupling between infrared photons and optically… Read MoreOct. 9, 2024
-
CFD Research Corporation Joins VINSE Industry Affiliates Program
CFD Research Corporation (CFDRC) is the latest member of the VINSE Industry Affiliates Program, expanding our collaboration with industry leaders in various fields. Known for its expertise in engineering simulations and cutting-edge designs, CFDRC serves a wide range of industries, including aerospace, biomedical, defense, materials, and energy. With access to… Read MoreOct. 9, 2024
-
Angstrom Engineering Joins the VINSE Industry Affiliates Program
Angstrom Engineering Inc. is now a proud member of the VINSE Industry Affiliates Program. Specializing in industry-leading thin film deposition systems for PVD and CVD processes, Angstrom Engineering tailors systems to specific process requirements and assembles them on-site with a dedicated team prioritizing quality, service, and performance. For more about… Read MoreOct. 8, 2024
-
VINSE Invites Community to Celebrate National Nanotechnology Day
The Vanderbilt Institute of Nanoscale Science and Engineering (VINSE) is thrilled to announce its annual celebration of National Nanotechnology Day on October 9. Held in recognition of the significance of the nanometer scale—10-9 meters—National Nanotechnology Day serves as a reminder of the innovative advances made in this field. VINSE will… Read MoreOct. 7, 2024
-
Dong receives NIH Trailblazer Award for innovative airway stent research to revolutionize treatment of COPD, lung conditions
Xiaoguang Dong, assistant professor of mechanical engineering, has been awarded an R21 Trailblazer Award by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health (NIH) to pursue a project about “Wirelessly Actuated Ciliary Stent… Read MoreSep. 30, 2024
-
VINSE at the TN Maker Fest
To share our love of making tiny things for science, VINSE participated in this year’s TN Maker Fest. VINSE NanoGuides showcase nanoscale using familiar items in three engaging interactive demonstrations. Pencils to Prizes – attendees made their own single-atom-thick materials like a Nobel Prize winner with tape and pencil… Read MoreSep. 30, 2024
-
Researcher Highlight: Taylor Sheehy
My research focuses on developing next-generation oncology immunotherapeutics. This unique class of drugs aims to modulate the body’s own immune system to recognize and eliminate cancer. With immune checkpoint blockade (ICB) therapy changing the paradigm of cancer treatment, clinicians and scientists are looking for new strategies to improve efficacy and… Read MoreSep. 24, 2024